Profiling the nucleobase and structure selectivity of anticancer drugs and other DNA alkylating agents by RNA-Seq

May 10, 2018 Leave a comment 1,537 Views

Drugs that covalently modify DNA are components of most chemotherapy regimens, often serving as first-line treatments. Classically the chemical reactivity of DNA alkylators has been determined in vitro with...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: alkylating chemotherapeutics

Profiling the nucleobase and structure selectivity of anticancer drugs and other DNA alkylating agents by RNA-Seq

Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression

ICRNASA 2022 – International Conference on RNA Sequencing and Analysis

New data suggest he percepta GSC RNA sequencing-based risk-stratification test can help accelerate timely treatment for patients with early-stage lung cancer

Quick determination of RNA-Seq strandedness

Benchmarking of a Bayesian single cell RNAseq differential gene expression test for dose–response study designs

Massively parallel direct RNA sequencing enables scientists to build ‘valves’ in DNA to shape biological information flows

Featured RNA-Seq Job – Research Associate/Senior Research Associate (Single Cell RNA Sequencing Library Preparation)